Serious central nervous system side effects of cephalosporins: A national analysis of serious reports registered in the French Pharmacovigilance Database
Clémence Lacroix(Inserm), Joëlle Micallef(Assistance Publique Hôpitaux de Marseille), François Montastruc(Centre d’Investigation Clinique 1436), Youssef Bennis(Université de Picardie Jules Verne), Véronique Pizzoglio(Hospices Civils de Lyon), Farid Kheloufi(Assistance Publique Hôpitaux de Marseille)
Cited by 60
Related Papers
French consensus regarding precautions during tracheostomy and post-tracheostomy care in the context of COVID-19 pandemic
|European Annals of Otorhinolaryngology Head and Neck Diseases|2020|76
Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug Reactions
|Clinical Pharmacology & Therapeutics|2021|48
Non-targeted screening for novel psychoactive substances among agitated emergency department patients
|Clinical Toxicology|2016|42
Cannabis for the treatment of amyotrophic lateral sclerosis: What is the patients’ view?
|Revue Neurologique|2023|32
Serious Neurological Adverse Events of Ceftriaxone
|Antibiotics|2021|29